A close, updated review of data used to determine how to improve lung cancer screening rates and see who is most at risk of pulmonary complications is necessary to make progress in this area, notes Ajay Sheshadri, MD, MSCI.
Ajay Sheshadri, MD, MSCI, associate professor of pulmonary medicine at the University of Texas MD Anderson Cancer Center, says that lung screening improvements and the implementation of race-neutral guidelines are crucial to keep in mind for future progress in pulmonary health.
Transcript
What do you hope will happen between CHEST 2023 and CHEST 2024 in terms of how disparities in lung health care are addressed?
There's a lot of things that need to improve. I don't know how many of them will improve in the span of 1 year; I think this is more of like a 10-year or even longer project. But it needs to improve sooner than later. Some of the specific things that I'd like to improve in the short term, are the access to lung cancer screening. In general, the amount of engagement that our population has with lung cancer screening is very, very low, and it's one of the most effective forms of cancer screening that we have. I'm hoping that some of the disparities that we have in engagement that are along, for example, racial lines or socioeconomic lines will be reduced over time and this screening will become more available.
I'm also hopeful that we'll improve access to cancer centers up front. I think there's a delay in getting cancer care, which impacts what we're able to do. That includes some folks presenting with a later stage, where some of the options that might have been available to us at earlier stage are no longer available. Of course, that feeds a little bit on more effective and more available screening.
Finally, from just a personal perspective, I hope we are able to implement race-neutral guidelines, but also take a critical reexamination of the existing data to understand what are the actual thresholds using race-neutral guidelines that dictate whether someone is at low, medium, or high risk for pulmonary complications? That's something that may require more time for us to collect new data. These data probably needs to be collected anyway, because some of the data that influenced the recommendations that have been made are many, many years old.
And so, I think it's time for us to understand what the true risk is with modern surgical techniques and do it with this lens of looking at everybody without applying race corrections to their lung function values.
A new federal rule will enable thousands of immigrants in the Deferred Action for Childhood Arrivals (DACA) program to obtain health care through the Affordable Care Act; a forthcoming CMS rule is expected to lower home-based care wait times and raise caregiver wages; the HHS Office for Civil Rights has finalized 2 rules that strengthen the ACA’s health care discrimination ban.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More